Papilloma Viral Infection

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Papilloma Viral Infection trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 35 trials

RecruitingPhase 2

NCT07454915

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

The purpose of this Phase 2 study is to compare the effects of administering the PVX4 combination device biologic product (pBI-4 DNA vaccine via electroporation…

United States, Taiwan138 participantsStarted 2026-04-01

Treatment: PVX4 Combination Product, Placebo Control

RecruitingPhase 3

NCT07457918

Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

People who participated in either the COVE-2 or COVE-3 study for common warts, may be eligible to enroll into this Long Term Follow Up (LTFU) study COVE-4. The…

United States600 participantsStarted 2026-03-11

Treatment: Cantharidin

RecruitingNot Applicable

NCT07060261

Pre-Op MRI on Margin Status for Transoral Robotic Surgery for HPV+ Tonsillar Squamous Cell Carcinoma

This prospective research study aims to see if pre-operative MRI can predict the margin status after transoral robotic surgery (TORS) for human papillomavirus p…

United States30 participantsStarted 2025-11-26

Treatment: Transoral robotic surgery+MRI

RecruitingNot Applicable

NCT06598475

Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve…

The purpose of this study is to determine the provider- and practice-level characteristics that influence the impact of implementation strategies guided by prac…

United States225 participantsStarted 2025-03-13

Treatment: Facilitator-driven provider- and practice-level implementation strategies for influencing provider recommendations and practice-level HPV vaccination rates

RecruitingNot Applicable

NCT07550010

Digital Telecytology for Triage of HPV-Positive Women in Cameroon

This study evaluates the diagnostic accuracy and feasibility of a same-day cervical cancer screening strategy using HPV self-sampling followed by digital telecy…

Cameroon1,800 participantsStarted 2025-09-08

Treatment: HPV testing (self-sampling), Digital telecytology

RecruitingPhase 2

NCT06157151

PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer

This Phase 2 study will evaluate the efficacy and safety of PRGN-2009 in combination with pembrolizumab in patients with pembrolizumab-resistant recurrent or me…

United States24 participantsStarted 2025-11-11

Treatment: PRGN-2009 plus Pembrolizumab

All recent trials (100 shown)

Not Yet RecruitingPhase 1

NCT06233331

Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV

The goal of this study is to test the maximum tolerated dose of ACU-D1 in HIV-positive people with HPV-associated vulvar and perianal lesions. The main question…

United States9 participantsStarted 2026-06

Treatment: Dose Level 1 ACU-D1 ointment, Dose Level 2 ACU-D1 ointment

Active — Not RecruitingPhase 2

NCT05797246

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Background: Recurrent respiratory papillomatosis (RRP) is a rare disease that causes wart-like growths in the airways. These growths come back when removed; so…

United States21 participantsStarted 2023-08-02

Treatment: Bevacizumab

Papilloma Viral Infection

Trial phase breakdown

Trial status

Actively recruiting — 35 trials

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

Pre-Op MRI on Margin Status for Transoral Robotic Surgery for HPV+ Tonsillar Squamous Cell Carcinoma

Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve…

Digital Telecytology for Triage of HPV-Positive Women in Cameroon

PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer

All recent trials (100 shown)

Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Trial phase breakdown

Trial status

Actively recruiting — 35 trials

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

Pre-Op MRI on Margin Status for Transoral Robotic Surgery for HPV+ Tonsillar Squamous Cell Carcinoma

Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve…

Digital Telecytology for Triage of HPV-Positive Women in Cameroon

PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer

All recent trials (100 shown)

Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

A Proximity-incentive Strategy for Cervical Cancer Screening

Human Papillomavirus Infection and Related Anal Lesions in HIV-positive Men Who Have Sex With Men

Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (C…

HPV Testing as a Prevention of Cervical Dysplasia and Cancer Before Planned Subtotal Hysterectomy

Impact of Standing Orders Optimization

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)

Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults V…

GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose

Effect of Health Belief Model-Based Education on Cervical Cancer Knowledge and HPV Vaccine Attitudes in Women

INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomat…

A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomaviru…

Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants

Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma

Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)